ANXA6 and breast neoplasm: We and others have also demonstrated that treatment of breast tumor cells with TKIs [21], nonselective Ca2+ channel blockers [103], and the DNA methyltransferase (DNMT) inhibitors 5-aza-2′-deoxycytidine or 5-aza-cytidine [114] led to AnxA6 upregulation.